Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Interest Expenses (2019 - 2025)

Bioadaptives' Interest Expenses history spans 7 years, with the latest figure at $11017.0 for Q4 2025.

  • Quarterly results put Interest Expenses at $11017.0 for Q4 2025, up 125.04% from a year ago — trailing twelve months through Dec 2025 was $44466.0 (up 895.31% YoY), and the annual figure for FY2025 was $44466.0, up 16.17%.
  • Interest Expenses for Q4 2025 was $11017.0 at Bioadaptives, down from $14153.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $251218.0 in Q4 2022 to a low of -$88132.0 in Q4 2021.
  • The 5-year median for Interest Expenses is $14993.0 (2021), against an average of $27303.5.
  • The sharpest move saw Interest Expenses plummeted 270.76% in 2021, then skyrocketed 385.05% in 2022.
  • Year by year, Interest Expenses stood at -$88132.0 in 2021, then skyrocketed by 385.05% to $251218.0 in 2022, then plummeted by 132.19% to -$80879.0 in 2023, then skyrocketed by 45.59% to -$44003.0 in 2024, then soared by 125.04% to $11017.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $11017.0, $14153.0, and $9649.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.